Hyperkalemia: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: In medicine, '''hyperkalemia''' is an "abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by [[elect...) |
imported>Howard C. Berkowitz No edit summary |
||
| Line 2: | Line 2: | ||
==Treatment== | ==Treatment== | ||
Treatment includes both emergency and continued therapy. | |||
===Emergency managment=== | |||
[[Insulin]] and [[beta-adrenergic agonist]]s are established therapies for lowering potassium levels. <ref name=AFP>{{citation | |||
| url = http://www.aafp.org/afp/2006/0115/p283.html | |||
| journal = American Family Physician | |||
| title = Hyperkalemia | |||
| author = Joyce C. Hollander-Rodriguez and James F. Calvert | |||
| date = 2006 Jan 15| volume = 73| issue = 2 | pages =283-290}}</ref> | |||
===Sodium polystyrene sulfonate=== | ===Sodium polystyrene sulfonate=== | ||
Sodium polystyrene sulfonate (Kayexalate) is widely used for continued lowering of potassium levels. While the resin proper is considered safe, the available preparations with it suspended in [[sorbitol]] may be dangerous. <ref name="pmid20167700">{{cite journal| author=Sterns RH, Rojas M, Bernstein P, Chennupati S| title=Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? | journal=J Am Soc Nephrol | year= 2010 | volume= 21 | issue= 5 | pages= 733-5 | pmid=20167700 | |||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=20167700 | doi=10.1681/ASN.2010010079 }} </ref><ref name="pmid19373153">{{cite journal| author=McGowan CE, Saha S, Chu G, Resnick MB, Moss SF| title=Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol. | journal=South Med J | year= 2009 | volume= 102 | issue= 5 | pages= 493-7 | pmid=19373153 | | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=20167700 | doi=10.1681/ASN.2010010079 }} </ref><ref name="pmid19373153">{{cite journal| author=McGowan CE, Saha S, Chu G, Resnick MB, Moss SF| title=Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol. | journal=South Med J | year= 2009 | volume= 102 | issue= 5 | pages= 493-7 | pmid=19373153 | ||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=19373153 | doi=10.1097/SMJ.0b013e31819e8978 }} </ref> | | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=19373153 | doi=10.1097/SMJ.0b013e31819e8978 }} </ref> | ||
Revision as of 21:17, 14 June 2010
In medicine, hyperkalemia is an "abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur."[1]
Treatment
Treatment includes both emergency and continued therapy.
Emergency managment
Insulin and beta-adrenergic agonists are established therapies for lowering potassium levels. [2]
Sodium polystyrene sulfonate
Sodium polystyrene sulfonate (Kayexalate) is widely used for continued lowering of potassium levels. While the resin proper is considered safe, the available preparations with it suspended in sorbitol may be dangerous. [3][4]
References
- ↑ Anonymous (2024), Hyperkalemia (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Joyce C. Hollander-Rodriguez and James F. Calvert (2006 Jan 15), "Hyperkalemia", American Family Physician 73 (2): 283-290
- ↑ Sterns RH, Rojas M, Bernstein P, Chennupati S (2010). "Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective?". J Am Soc Nephrol 21 (5): 733-5. DOI:10.1681/ASN.2010010079. PMID 20167700. Research Blogging.
- ↑ McGowan CE, Saha S, Chu G, Resnick MB, Moss SF (2009). "Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol.". South Med J 102 (5): 493-7. DOI:10.1097/SMJ.0b013e31819e8978. PMID 19373153. Research Blogging.